
Metformin (1000mg) + Glimepiride (2mg)
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glycostar M Forte 2mg/1000mg Tablet SR is a combination oral hypoglycemic agent containing Glimepiride 2mg and Metformin 1000mg in a sustained-release formulation. It is indicated for the management of type 2 diabetes mellitus, particularly in patients inadequately controlled on diet and exercise alone or those already receiving monotherapy with either agent. Glimepiride, a sulfonylurea, stimulates pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, contributing to enhanced glycemic control. The sustained-release formulation allows for once-daily dosing, improving patient compliance and minimizing gastrointestinal side effects commonly associated with immediate-release metformin. Glycostar M Forte is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment, and conditions predisposing to hypoxia. Caution is advised in patients with cardiovascular disease and elderly patients. Regular monitoring of blood glucose, renal function, and hematologic parameters is recommended during therapy. This combination therapy offers a synergistic approach to glycemic management, optimizing efficacy while reducing the risk of hypoglycemia compared to sulfonylurea monotherapy.
How to use Glycostar M Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glycostar M Forte 2mg/1000mg Tablet SR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glycostar M Forte 2mg/1000mg Tablet SR.
High Risk
Glycostar M Forte 2mg/1000mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glycostar M Forte 2mg/1000mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glycostar M Forte 2mg/1000mg Tablet SR may be needed. Please consult your doctor. Glycostar M Forte 2mg/1000mg Tablet SR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Glycostar M Forte 2mg/1000mg Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Glycostar M Forte 2mg/1000mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glycostar M Forte 2mg/1000mg Tablet SR may be needed. Please consult your doctor. Use of Glycostar M Forte 2mg/1000mg Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Glycostar M Forte 2mg/1000mg Tablet SR

Glimepiride (2mg) + Metformin (1000mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Medical applications
Glycostar M Forte 2mg/1000mg Tablet SR is a combination oral hypoglycemic agent containing Glimepiride 2mg and Metformin 1000mg in a sustained-release formulation. It is indicated for the management of type 2 diabetes mellitus, particularly in patients inadequately controlled on diet and exercise alone or those already receiving monotherapy with either agent. Glimepiride, a sulfonylurea, stimulates pancreatic beta cells to increase insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, contributing to enhanced glycemic control. The sustained-release formulation allows for once-daily dosing, improving patient compliance and minimizing gastrointestinal side effects commonly associated with immediate-release metformin. Glycostar M Forte is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment, and conditions predisposing to hypoxia. Caution is advised in patients with cardiovascular disease and elderly patients. Regular monitoring of blood glucose, renal function, and hematologic parameters is recommended during therapy. This combination therapy offers a synergistic approach to glycemic management, optimizing efficacy while reducing the risk of hypoglycemia compared to sulfonylurea monotherapy.
How to use Glycostar M Tablet SR Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glycostar M Forte 2mg/1000mg Tablet SR is to be taken with food.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
It is unsafe to consume alcohol with Glycostar M Forte 2mg/1000mg Tablet SR.
High Risk
Glycostar M Forte 2mg/1000mg Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Glycostar M Forte 2mg/1000mg Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glycostar M Forte 2mg/1000mg Tablet SR may be needed. Please consult your doctor. Glycostar M Forte 2mg/1000mg Tablet SR is generally started with a low dose in patients with mild to moderate liver disease, and its use is not recommended in patients with severe liver disease.
Regular Checkup
Glycostar M Forte 2mg/1000mg Tablet SR is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Consult Doctor
Glycostar M Forte 2mg/1000mg Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Glycostar M Forte 2mg/1000mg Tablet SR may be needed. Please consult your doctor. Use of Glycostar M Forte 2mg/1000mg Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function tests is advisable while you are taking this medicine.
Regular Checkup
0 reviews for Glycostar M Forte 2mg/1000mg Tablet SR













